• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cyclo Therapeutics Inc (NQ: CYTH )

    1.230 +0.030 (+2.50%)
    Streaming Delayed Price Updated: 2:56 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,502
    Open 1.245
    Bid (Size) 1.220 (1)
    Ask (Size) 1.240 (1)
    Prev. Close 1.200
    Today's Range 1.210 - 1.245
    52wk Range 0.8924 - 2.124
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
    Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential 
    From Rafael Holdings, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -25.90%
    -25.90%
    1 Month
    -4.65%
    -4.65%
    3 Month
    -9.56%
    -9.56%
    6 Month
    -25.90%
    -25.90%
    1 Year
    -24.54%
    -24.54%

    More News

    Read More
    Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023
    Via InvestorPlace
    Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Topics Earnings
    Exposures Financial
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.